Asgard Therapeutics
Latest round
- Series A
Last raised
- Mar 2024
Total raised
- $39M
Investors
- 5
About Asgard Therapeutics
Founded in 2018 and based in Lund, Sweden, Asgard Therapeutics, a spin-off from Lund University, is a biotechnology company that develops cancer immunotherapies based on cell fate reprogramming. Asgard Therapeutics' lead program, AT-108, leverages its TrojanDC concept to create off-the-shelf gene therapies that convert cancer cells into antigen-presenting cells, thus facilitating immune responses against tumors. The company's approach addresses common challenges in traditional cell-based therapies, such as logistics and manufacturing. Additionally, its platform enhances scalability and efficiency in immunotherapy.
Who invested in Asgard Therapeutics
5 investors across 2 rounds
See all investors in Asgard Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Asgard Therapeutics
Who invested in Asgard Therapeutics?
Asgard Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Asgard Therapeutics raised?
Asgard Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Asgard Therapeutics last raise money?
Asgard Therapeutics's most recent round on record is a Series A, in Mar 2024.
What does Asgard Therapeutics do?
Founded in 2018 and based in Lund, Sweden, Asgard Therapeutics, a spin-off from Lund University, is a biotechnology company that develops cancer immunotherapies based on cell fate reprogramming.
Where is Asgard Therapeutics headquartered?
Asgard Therapeutics is headquartered in Lund, Sweden.
Which VCs invest in companies like Asgard Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Asgard Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Asgard Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.